We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN and WuXi AppTec Enter into Partnership Agreement for Molecular Biomarker Development

News   Jan 12, 2010

 
QIAGEN and WuXi AppTec Enter into Partnership Agreement for Molecular Biomarker Development
 
 
 

RELATED ARTICLES

Tuberculosis Tests are Inadequate, Better Options Identified

News

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

READ MORE

‘Shortcut’ Transforms Terpene Biosynthesis in E. Coli

News

Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.

READ MORE

Yeast Model of Metabolic Disorders May Lead to Novel Therapies

News

Researchers suggests that the role of yeast, the world's most basic eukaryotic unicellular organism, may pave the way for the development of novel, more effective therapies for the treatment of metabolic disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE